Last update:

Immunology news

Immunology

Here's why B cells benefit from booster shots

Certain infectious diseases, such as COVID or the flu, evolve constantly, shapeshifting just enough to outmaneuver our immune systems and reinfect us repeatedly. But subsequent reinfections often don't lead to the most severe ...

Immunology

Scientists discover new mechanism controlling T-cells in inflammation

Northwestern Medicine scientists have discovered a new mechanism that controls a specialized group of T-cells, known as regulatory T-cells, and may serve as potential therapeutic targets to treat inflammatory disorders and ...

Cardiology

New cardiovascular disease risk marker discovered in older women

Researchers at Karolinska Institutet have identified a new potential risk marker for cardiovascular disease in women. A new study shows an association between low levels of an anti-inflammatory antibody and the risk of heart ...

Oncology & Cancer

Blood cancers: Expert explains what you need to know

Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.

Oncology & Cancer

What is CAR-T cell therapy? Oncologist explains

Roughly 635,000 new cases of lymphoma were diagnosed worldwide, according to the World Cancer Research Fund International's most recent report. Survival rates for aggressive lymphomas have improved significantly thanks to ...

Oncology & Cancer

Why lung cancer doesn't respond well to immunotherapy

Immunotherapy—drug treatment that stimulates the immune system to attack tumors—works well against some types of cancer, but it has shown mixed success against lung cancer.

Oncology & Cancer

Boosting anti-cancer antibodies by reducing their grip

New research from the Centre for Cancer Immunology at the University of Southampton, published ahead of World Cancer Day (February 4), has shown that changing how tightly an antibody binds to a target could improve treatments ...

Oncology & Cancer

Review covers progress in immunotherapy for esophageal cancer

Esophageal cancer (EC) is one of the most common types of cancer worldwide and was ranked as the sixth leading cause of cancer-related deaths in 2020. When EC is localized or locally advanced, referred to as resectable EC, ...

Cardiology

Why arteriosclerosis looks like an autoimmune disease

Arteriosclerosis bears great similarities to autoimmune diseases. Researchers from Leiden University show this in a new study they published in the journal Nature Cardiovascular Research. "This discovery suggests that treatment ...

Oncology & Cancer

How sound waves trigger immune responses to cancer in mice

When non-invasive sound waves break apart tumors, they trigger an immune response in mice. By breaking down the cell wall "cloak," the treatment exposes cancer cell markers that had previously been hidden from the body's ...

Immunology

Computer model predicts who will recover from COVID-19

Scientists have tracked the detailed biology and biochemistry of people infected with COVID-19 to reveal exactly how our bodies respond to the disease—and have built a predictive model to identify individual chances of ...

Immunology

Study reframes understanding of graft-versus-host disease

New research challenges the prevailing hypothesis for how donor stem cell grafts cause graft-versus-host disease, or GVHD, and offers an alternative model that could guide development of novel therapies.

Oncology & Cancer

How a leukemia hijacks the genes needed by blood stem cells

As a child, Lynn Aureli didn't know that a particular genetic change contributed to her acute myeloid leukemia (AML)—an alteration that eventually would help explain the cancer's lack of response to chemotherapy. Nor was ...